Table 1 General characteristics of 182 GC patients
Variables | Values |
|---|---|
Age (years) | 70 (38–90) |
≥ 70 / < 70 | 92 (50.5%) / 90 (49.5%) |
Sex | |
male / female | 130 (71.4%) / 52 (28.6%) |
BMI (kg/m2) | 22.7 (14.2–35.8) |
≥ 25 / < 25 | 49 (26.9%) / 133 (73.1%) |
Comorbidities | |
Myocardial infarction | 7 (3.8%) |
Congestive heart failure | 11 (6.0%) |
Cerebrovascular accident | 12 (6.6%) |
COPD | 14 (7.7%) |
Liver disease | 6 (3.3%) |
Chronic kidney disease | 2 (1.1%) |
Diabetes mellitus | 35 (19.2%) |
Stage | |
I / II / III | 114 (62.6%) / 38 (20.9%) / 30 (16.5%) |
Depth of tumor invasion (T) | |
1 / 2 / 3 / 4 | 99 (54.4%) / 23 (12.6%) / 55 (30.2%) / 5 (2.7%) |
Tumor size (mm) | 40 (4–140) |
≥ 50 / < 50 | 59 (32.4%) / 123 (67.6%) |
Lymph node metastasis (N) | |
0 / 1 / 2 / 3 | 127 (69.8%) / 25 (13.7%) / 13 (7.1%) / 17 (9.3%) |
Lymphatic vessel infiltration | 80 (44.0%) |
Histologic type | |
Intestinal / Diffuse | 102 (56.0%) / 80 (44.0%) |
Approach | |
Open / Laparoscopic | 93 (51.1%) / 89 (48.9%) |
Operative method | |
Distal / Total / Proximal | 124 (68.1%) / 51 (28.0%) / 7 (3.8%) |
Lymph node dissection | |
D1 / D1+ / D2 | 32 (17.6%) / 74 (40.7%) / 76 (41.8%) |
Complication (CD ≥ 3) | 9 (4.9%) |
Complication (infection) | 14 (7.7%) |
Length of stay (day) | 13 (8–178) |
≥ 20 / < 20 | 26 (14.3%) / 156 (85.7%) |
Tumor markers | |
CEA (ng/mL) | 2.6 (0.5–68.8) |
≥ 5.5 / < 5.5 | 18 (9.9%) / 164 (90.1%) |
CA19–9 (ng/mL) | 7.35 (0.1–1048.3) |
≥ 37 / < 37 | 19 (10.4%) / 163 (89.6%) |
mGPS | |
0 / 1 / 2 | 167 (91.8%) / 7 (3.8%) / 8 (4.4%) |
NLR | 2.0 (0.56–15.37) |
≥ 2.5 / < 2.5 | 59 (32.4%) / 123 (67.6%) |
PNI | 44.1 (26.0–64.7) |
≥ 45 / < 45 | 85 (46.7%) / 97 (53.3%) |
Adjuvant chemotherapy | 33 (18.1%) |